Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Evaluate the safety and tolerability of ADX-038 Description: Incidence and severity of TEAEs Time frame: Length of study - 36 months. After: Measure: Evaluate the safety and tolerability of ADX-038 Description: Incidence and severity of TEAEs Time frame: Length of study - From Day 1 through Month 24.
Planned enrollment increased by 40 participants
Before: 45 participants (planned). After: 85 participants (planned).
Primary completion date changed
Before: 31 Dec 2028. After: 30 Apr 2030.